AzTrials
AzTrials

Malnutrition, ChildNCT05551819

Acceptability of a Microbiome-directed Food in Young Children With Acute Malnutrition

A study testing MDF then RUTF/RUSF and RUTF/RUSF then MDF in people with Malnutrition, Child, run by Epicentre at 2 sites in Niger.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This study will compare the acceptability a microbiome-directed food (MDF) with standard formulations of therapeutic/supplementary foods for the treatment of acute malnutrition using a 2 x 2 crossover design. Read more about this study

Who is it for?
Ages 6 to 23 months
Conditions the study is for
Malnutrition, Child
What is being tested?
MDF then RUTF/RUSF and RUTF/RUSF then MDF
Could I receive a placebo?
No, everyone receives an active treatment
How many people
274 participants
Where
2 sitesNiger
Study dates
26 Oct 2022to 16 Mar 2023
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 23 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Are eligible for outpatient treatment of severe or moderate acute malnutrition according to the national protocol
  • Are between 6 and <24 months of age
  • Reside in the study catchment area and will remain there for at least 1 month
  • Have no known allergy or contraindication to study product or standard treatment ingredients

Who cannot join

None listed.

Trial locations and contacts

2 sites in 1 country.

Niger2 sites
  • Guidan Roumji Health District

    Guidan Roumji

  • Madarounfa Health District

    Madarounfa

Other trials in Niger

About this study

Official title: Acceptability of a Microbiome-directed Food for the Treatment of Children With Uncomplicated Acute Malnutrition in Niger

This study will compare the acceptability a microbiome-directed food (MDF) with standard formulations of therapeutic/supplementary foods for the treatment of acute malnutrition using a 2 x 2 crossover design.

Read the detailed description

A randomized controlled trial will be conducted to assess the effectiveness of a microbiome-directed food (MDF) for treatment of uncomplicated acute malnutrition among children 6 to <24 months of age in Niger. MDF will be compared to standard ready-to-use therapeutic foods (RUTF) for children with severe acute malnutrition (SAM) and to standard ready-to-use supplementary foods (RUSF) for children with moderate acute malnutrition (MAM). The acceptability and utilization of MDF will be assessed in this preliminary acceptability study before the proposed effectiveness trial. The results of this preliminary acceptability study will be used to inform expectations of MDF use during the subsequent randomized effectiveness trial.

Children aged 6 to < 24 months will be eligible for enrollment in the acceptability trial on the day of their admission for treatment of uncomplicated severe or moderate acute malnutrition. Participants will be purposively selected to ensure balance by child age (6-11 vs 12 to < 24 months) and sex. Recruitment will occur continuously (e.g. without sampling on consecutive working days) among all eligible children at 2 study health centers until the target sample size is achieved.

After providing written informed consent, children will be randomized to 1 of 2 feeding orders (MDF vs RUTF/RUSF). Children will be randomized and provided with one product for the first two weeks then crossover to consume the second product for a second two weeks.

At each follow up visit, study nurses will ask caregivers rate their child's liking of the supplement on a 5-point Likert scale, as well as record child weight and any morbidity or adverse event since last visit before dispensing the next supply of food. Caregivers will also be asked to describe at-home utilization, including the food consumed by the child, current eating patterns in relation to other household foods (e.g. use at mealtimes, as a complete replacement, replacement of specific food items), sharing or selling practices in the home and willingness to use the supplement in the future.

Being tested
MDF then RUTF/RUSF, RUTF/RUSF then MDF
Medical subject headings
Child Nutrition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MDF then RUTF/RUSFDietary supplement

    Children randomized to feeding order 1: children will be provided MDF for the first two weeks then crossover to consume RUTF/RUSF for a second two weeks.

  • RUTF/RUSF then MDFDietary supplement

    Children randomized to feeding order 2: children will be provided RUTF/RUSF for the first two weeks then crossover to consume MDF for a second two weeks.

Study groups in NCT05551819
Study groupRoleWhat they receive
Feeding Order 1ExperimentalMDF then RUTF/RUSF
Receives: Dietary Supplement: MDF then RUTF/RUSF
Feeding Order 2ExperimentalRUTF/RUSF then MDF
Receives: Dietary Supplement: RUTF/RUSF then MDF

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of at-home ration

    Consumption of 75% or more of the supplement provided during each 2-week period, where consumption is defined as total amount of food provided minus the total amount of food returned unused divided by the total amount of food provided.

    Measured: 2 weeks

  2. Acceptability of test dose

    Consumption of 75% or more of the test dose within 30 minutes

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2022
  2. Study start26 Oct 2022
  3. Primary completion16 Mar 2023
  4. Study completion16 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
274 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05551819
Sponsor's protocol ID
823779-MDF Acceptability Niger
Status last verified
Apr 2024
First submitted
20 Sep 2022
Last updated
17 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rattigan SM, Mbouombouo IN, Abdou Tahirou MA, Mostafa I, Saqeeb KN, Garba S, Guindo O, Ahmed T, Barratt MJ, Gordon JI, Sudfeld CR, Grais RF, Isanaka S. Acceptability of a Microbiome-Directed Food for the Management of Children with Uncomplicated Acute Malnutrition in Maradi, Niger: Two Randomized Crossover Trials. Curr Dev Nutr. 2025 Jun 9;9(7):107484. doi: 10.1016/j.cdnut.2025.107484. eCollection 2025 Jul.

    PubMed 40672125

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in